25Bio funds breakthrough technologies that alter or prevent processes that set diseases in motion.

Our mission is to find and fund visionary entrepreneurs, working on technological breakthroughs with the potential to dramatically extend healthspan and lifespan.

Our Strategy

We believe that the combination of AI , scientific research, and demographic shift has created a once-in-a-generation opportunity to transform our health into the last decade of our life. 

Focused on What We Know

Therapeutics & TechBio platforms targeting regeneration, ageing and age related diseases.

Precision Biomarkers allowing real time at home monitoring and personalized preventive care.

Biowearables & tools for data-driven lifestyle interventions.

These are a few examples of areas within our investment focus. 


Investment in Founders with Venture Level Ambition

We are a partner with founders working on truly breakthrough technologies with long odds of extraordinary outcomes.

We are looking for founders with bold vision, conviction and first principles approach.

Biology is complex and the determined founder can reach the escape velocity to transform the field of longevity and healthy ageing.





Early In & High Conviction

We invest globally – great science and a great team is what matters to us.

We invest seed stage onwards when some technical risk has been removed.

We see ourselves as improving the probability of success and not just through providing capital.

Our Team

We are entrepreneurs and operators, bring deep insight, expertise and broad networks. We know the entrepreneurial journey is long and hard and are your partners on the way.

Swati Mehta
Managing Partner

Dr. Werner Seiz
Scientific Partner

Latest News & Insights

AI in Drug Discovery & Development: Cognitive Amplifier or Guardian Angel […]
The 2025 Nobel Prize in Medicine awarded to, Mary E. Brunkow, Fred Ramsdell, […]
Even today in October 2025, the health technology landscape is one where B2B […]